Joyce, E;
(2022)
‘Adults with Parkinson's disease and hallucinations or delusions can have treatment with clozapine if they need to’.
BJPsych Advances
, 28
(2)
pp. 99-101.
10.1192/bja.2021.61.
Preview |
Text
Joyce_Adults with Parkinson’s disease and hallucinations or delusions can have treatment with clozapine if they need to. Commentary on Setting up a clozapine se.pdf - Accepted Version Download (134kB) | Preview |
Abstract
Clozapine is the only antipsychotic licensed for treatment of Parkinson's disease psychosis (PDP) but is infrequently used in the National Health Service because of obstacles to the integration of hospital-based neurological/geriatric services with clozapine clinics run by community mental health teams. This commentary points out the mismatch between NICE quality standards on antipsychotic treatment for PDP and current clinical practice. It suggests that forthcoming integrated care systems should be able to overcome these obstacles, enabling innovative models for providing clozapine treatment for PDP such as those described by Taylor et al, so that clozapine treatment becomes a right for patients and their families.
Archive Staff Only
 |
View Item |
